embecta to Report Fiscal Second Quarter 2024 Financial Results
April 23, 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
March 06, 2024 06:00 ET
|
Embecta Corp.
embecta announces sponsorship of a symposium and 6 abstracts at the Advanced Technologies & Treatments for Diabetes (ATTD) international conference.
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
February 09, 2024 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month...
embecta Announces Quarterly Cash Dividend
February 09, 2024 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
embecta to Participate in the 11th Annual BTIG MedTech Conference
February 07, 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will host one-on-one investor meetings on Tuesday, February 13, 2024, at...
embecta to Report Fiscal First Quarter 2024 Financial Results
January 24, 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
January 09, 2024 06:00 ET
|
Embecta Corp.
embecta has submitted a 510(k) premarket filing to the FDA for a proprietary disposable insulin delivery system.
embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
December 14, 2023 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on...
No embecta-made syringes impacted by FDA safety communication
December 01, 2023 06:00 ET
|
Embecta Corp.
Embecta Corp. issued a statement regarding the FDA's safety communication on evaluation of certain plastic syringes
embecta to Participate in Investor Conferences
November 29, 2023 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following...